Skip to main content
CDC Website

English

Third Trimester Pregnancy Screening for Syphilis and HIV

This information sheet highlights syphilis and HIV screening practices for pregnant women. The Centers for Disease Control and Prevention (CDC) recommends prenatal testing for syphilis and HIV during a woman’s first prenatal visit and repeat testing for “high-risk” mothers during the third trimester (preferably 28-32 weeks).

HIV and Injection Drug Use Syringe Services Programs for HIV Prevention

This Vital Signs highlights the importance of expanding access to SSPs, which provide sterile needles and syringes and ideally offer many other comprehensive services to help improve the health of PWID and their communities, such as treatment for substance use disorder, HIV, and hepatitis testing and linkage to treatment, and safe disposal of used syringes.

The Case For New Multipurpose Prevention Technologies

Lauren Hunter, a doctoral student at UC Berkeley, presented the "Contraceptive method use and chlamydia positivity among California family planning clients: the case for new Multipurpose Prevention Technologies," an analysis comparing chlamydia positivity by type of contraceptive method used among women tested through California's Family PACT program in 2012-2013. In the presentation, she discusses the implications of the findings and how the development and provision of additional Multipurpose Prevention Technologies (MPTs) may help to address an unmet need for STI prevention.

HBV ECHO: Reducing Perinatal Transmission

Video developed through partnership with the Department of Health and Human Resources (HHS) Health Resources and Services Administration's (HRSA) Bureau of Primary Health Care, Project ECHO launched HBV ECHO, a national technical assistance program that helps enhance HRSA-funded health center capacity to reduce perinatal transmission of hepatitis B. Panelists discuss the teleECHO™ curriculum, challenges in addressing perinatal HBV in the primary care setting, and patient case studies.